Skip to content

Ayahuasca: all studies

Page 117 of 167: studies 1,161 to 1,170 of 1,662, newest first. Back to the ayahuasca overview

Research

Psychedelics and music: characterising changes in hierarchy of brain dynamics among the Santo Daime

Oxford University Research Archive (ORA) (University of Oxford) 2026 K Jerotic

The last few decades have been characterised by a resurgence in research and clinical interest in classic serotonergic psychedelics including N,N-dimethyltryptamine (DMT), lysergic acid diethylamide (LSD) and psilocybin, with a growing body of literature pointing to their treatment potential. Ayahuasca is a psychedelic brew commonly composed of plants carrying the psychoactive compound DMT, and...

Juremahuasca, a Sacrament to Challenge All Doctrines

Copernicus books 2026 Marcelo Leite

AbstractThis chapter delves into the meandrous trajectory of DMT extracted from Mimosa tenuifora (black jurema) along traditional, scientific, and neo-shamanic uses. Chemist Jonathan Ott popularized a recipe of anahuasca (sometimes called juremahuasca or pharmahuasca) mixing the root bark powder from the tree that grows in semi-arid regions of tropical America with Syrian rue as a source of...

DOI: 10.1007/978-3-032-22705-8_5 (opens in new tab) Government linguistics Action physics Subject documents Perspective graphical +1

Changa and DMT Crystals, Engines of Cosmopolitan Neo-Shamanism

Copernicus books 2026 Marcelo Leite

Festival in the state of Bahia, a Umbanda terreiro in Pernambuco and a Catimbó ritual in Rio Grande do Norte. The first experience was provided by a smokable version known as changa that became popular among psychonauts. Changa is supposed to have been invented in Australia, but using acacia instead of jurema as the source of DMT, a preparation also referred to as “aussiewaska,” according to...

DOI: 10.1007/978-3-032-22705-8_6 (opens in new tab) Perspective graphical Identity music Government linguistics Context archaeology +1

Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [¹⁸F]FDG-PET study

Repository for Publications and Research Data 2026 Klemens Egger, Robert Bozsak, Helena Aicher et al.

Classical psychedelics such as N,N-dimethyltryptamine (DMT) modulate consciousness via serotonergic receptor agonism, and are increasingly investigated for their psychotherapeutic potential. When combined with the monoamine oxidase A (MAO-A) inhibitor harmine—mimicking the pharmacological profile of ayahuasca—oral DMT induces a psychedelic experience lasting 4–5 h. While some neuroimaging...

DOI: 10.3929/ethz-c-000801722 (opens in new tab) Harmine Placebo Neuroimaging Metabolite +9

From Acute Altered States to Durable Change: A Social-Psychological Framework for Contextual Framing, Integration, and Post-Acute Stabilization

International Journal of Research and Innovation in Social Science 2026 Elias Rubenstein

Recent psychedelic research has shown that compounds such as psilocybin, DMT, ayahuasca, and 5-MeO-DMT can induce acute altered states involving self-dissolution, altered reality-status, and heightened meaning attribution. Historical and cross-cultural evidence likewise suggests that nonordinary states have often been embedded within ritual, initiation, contemplative discipline, and structured...

DOI: 10.47772/ijriss.2026.100500234 (opens in new tab) Full text (opens in new tab) Contemplation Meaning existential Existentialism Identity music +6

Natural Hallucinogens in Clinical Studies: A Review of Therapeutic Efficacy and Methodological Limitations

Farmacja Polska December 30, 2025 Ewa Niedzielska-Andres, Angelika Ziaja, Stanisław Zielinski et al.

Przedmiot badań: W ostatnich latach obserwuje się rosnące zainteresowanie wykorzystaniem naturalnych halucynogenów w leczeniu zaburzeń psychicznych, uzależnień czy bólu. Substancje takie jak psylocybina, ayahuasca, ibogaina czy meskalina poddawane są ocenie w badaniach klinicznych, które wskazują na ich potencjał terapeutyczny, zwłaszcza w leczeniu depresji lekoopornej, zespołu stresu...

DOI: 10.32383/farmpol/215392 (opens in new tab) Gynecology Traditional medicine Theology

Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

Journal of Clinical Medicine December 29, 2025 Monika Dominiak, Adam Gędek, Szymon Modrzejewski et al. 2 citations

Background: Psychedelic-assisted therapy is gaining renewed attention as a potential treatment for various mental disorders. Despite increasing numbers of randomized controlled trials (RCTs) and meta-analyses, a comprehensive synthesis of the evidence across different substances and indications is lacking. This umbrella review aims to evaluate the effectiveness and safety of...

A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder

Current Treatment Options in Psychiatry December 26, 2025 Manasicha P. Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon et al.

Purpose A systematic review was conducted to synthesize the efficacy, safety, and tolerability of psychedelics including ketamine, MDMA, ayahuasca, LSD, DMT, ibogaine, and psilocybin in the treatment of PTSD. Recent Findings Among 5,155 studies identified, 42 studies met criteria and were included in our systematic review. Ketamine consistently produced rapid symptom improvement that attenuated...

Digital Enablement of Psychedelic-Assisted Therapy in Non-Clinical Settings: A Systematic Review of Safety, Efficacy, and Implementation Models

Psychoactives December 24, 2025 Brendan Driscoll, Shaheen E. Lakhan 1 citation

Psychedelic-assisted therapy offers rapid and profound benefits for treatment-resistant psychiatric conditions but remains constrained by the need for intensive, clinic-based administration. Concurrently, advances in digital health technologies have introduced scalable tools. This systematic review evaluates the safety, efficacy, and implementation of digitally enabled psychedelic-assisted...

Psychedelics in Psychiatry: New Treatment Paradigms or Addictive Treatment Strategies? A Narrative Review

Pharmaceutical Science December 9, 2025 Marco Otto Toscano, Serena Chiara Civardi, Federico Durbano

Scientific interest in psychedelics, documented since the nineteenth century, has recently resurged after decades of prohibition. Contemporary research highlights their therapeutic potential in treatment-resistant psychiatric disorders, alongside their heuristic value for studying brain networks and consciousness. This chapter reviews the historical trajectory, traditional uses, mechanisms of...

DOI: 10.5772/intechopen.1014070 (opens in new tab) Enthusiasm Narrative review Perspective graphical Ambivalence +7